AUTL
Autolus Therapeutics Ltd - ADR

3,378
Loading...
Loading...
Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells. The company was founded by Martin Pule in September 2014 and is headquartered in London, the United Kingdom.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
647

Frequently Asked Questions

What is Market Cap of Autolus Therapeutics plc - ADR?
What is the 52-week high for Autolus Therapeutics plc - ADR?
What is the 52-week low for Autolus Therapeutics plc - ADR?
What is Autolus Therapeutics plc - ADR stock price today?
What was Autolus Therapeutics plc - ADR stock price yesterday?
What is the PE ratio of Autolus Therapeutics plc - ADR?
What is the Price-to-Book ratio of Autolus Therapeutics plc - ADR?
What is the 50-day moving average of Autolus Therapeutics plc - ADR?
How many employess does Autolus Therapeutics plc - ADR has?

Latest AUTL News

View

Advertisement. Remove ads.

Advertisement. Remove ads.